http://lookfordiagnosis.com
English
Spanish
Italian
Portuguese
French
Swedish
GSK announces approval in Canada for Incruse™ Ellipta™ (umeclidinium) as a ...
For over 40 years GSK has been at the forefront of research and development of new respiratory medicines, and our goal in COPD is to introduce a range of medicines so that physicians can choose the treatment option which best meets their individual ...
Canada NewsWire (press release) - Thu, 17 Apr 2014 08:33

GSK announces approval in Canada for Incruse(TM) Ellipta(TM) (umeclidinium ...
MarketWatch - Thu, 17 Apr 2014 10:03



FDA Approves Merck's Allergy Immunotherapy
Grastek is contraindicated in patients with severe, unstable or uncontrolled asthma; a history of any severe systemic allergic reaction; a history of any severe local reaction after taking any sublingual allergen immunotherapy; a history of ...
Drug Discovery & Development - Tue, 15 Apr 2014 11:02

FDA Approves Merck's GRASTEK® (Timothy Grass Pollen Allergen Extract ...
EIN News (press release) - Mon, 14 Apr 2014 14:56

Zogenix Announces Ruling Preventing the Implementation of Massachusetts ...
Zohydro ER is contraindicated in patients with: significant respiratory depression; acute or severe bronchial asthma or hypercarbia; known or suspected paralytic ileus; and hypersensitivity to hydrocodone bitartrate or any other ingredients in Zohydro ER.
Wall Street Journal - Tue, 15 Apr 2014 12:52



GSK Receives US Approval For Once-Weekly Type 2 Diabetes Treatment ...
Do not use in patients with a prior serious hypersensitivity reaction to albiglutide or to any of the product components. WARNINGS AND PRECAUTIONS. Pancreatitis: Discontinue promptly if suspected. Do not restart if ... Adverse reactions, reported in ...
Med Device Online (press release) - Tue, 15 Apr 2014 10:03

GSK receives US approval for once-weekly type 2 diabetes treatment, Tanzeum ...
Wall Street Journal - Tue, 15 Apr 2014 10:03



PRAC Starts Review on Ambroxol, Bromhexine Meds
Injection formulations are available for use in premature and newborn babies to treat respiratory distress syndrome, in which a baby's lungs are immaturely developed. The drugs are authorized in 28 European jurisdictions. The committee will be ...
Medscape - Fri, 11 Apr 2014 13:57

In adults with upper limb spasticity, treatment with Dysport ® demonstrated ...
Dysport® (abobotulinumToxinA) is contraindicated in individuals with known hypersensitivity to any of its components. SPECIAL WARNINGS AND PRECAUTIONS FOR USE. Adverse effects resulting from the distribution of the effects ... Patients and their care ...
Business Wire (press release) - Sat, 12 Apr 2014 03:52

Anoro Ellipta by GlaxoSmithKline and Theravance, Inc
Use of Anoro Ellipta is contraindicated in patients with severe hypersensitivity to milk proteins, umeclidinium, vilanterol, or any of the components of Anoro Ellipta. Treatment with Anoro Ellipta should not be initiated in patients with acutely ...
Pharmacy Times - Fri, 11 Apr 2014 09:18

PARIS — Regulatory News:
Dysport® (abobotulinumToxinA) is contraindicated in individuals with known hypersensitivity to any of its components. SPECIAL WARNINGS AND PRECAUTIONS FOR USE. Adverse effects resulting from the distribution of the effects ... Patients and their care ...
Fort Mills Times - Sat, 12 Apr 2014 03:52


1  2  3  4  5  6  7  8    ->

Last update: April 2009
Statistics